VALEO PHARMA ANNOUNCES HEALTH CANADA APPROVAL FOR REDESCA(TM) AND REDESCA HP(TM) (VPH) (VPHIF) (VP2) – December 9, 2020 – RICH TV LIVE – Valeo Pharma Inc . (CSE:VPH) (OTCQB: VPHIF) (FSE: VP2) (” Valeo ” or the ” Company “), a Canadian pharmaceutical company, announced today that Health Canada has issued a Notice of Compliance for Redesca and Redesca HP low molecular weight heparin (“LMWH”) biosimilars.
Hey guys how you doing this is rich from behavior rich tv live and today i want to speak to you about valeo pharma i brought you this pick around 75 cents in early november today they sit at a dollar 30. congratulations to all members on this big winner vph in canada and vphif in america you can clearly see that it has gone up from the lows in america to where it
Is right now as i predicted it would where it is currently trading at an all-time high okay currently at 131 trading right around the all-time high and when we first started we marked the the low to the high and predicted that it could go as high as 130 it did it went as high as actually 131 actually 130 came back down and it’s come back up so this is extremely
Bullish and now we can kind of look at this like this since we started and we found this around 75 cents and in about five weeks we are now at a dollar thirty so congratulations to all members and they have some big news today and let’s break down this news valeo pharma announces health canada approval for red desk trademark and radesca hp trademark commercial
Launch to impact first half of 2021 revenue 30 million forecasted annual peak sales that is huge eight years of proven in market safety internationally low molecular weight heparin increasingly used to prevent covin 19 driven complications this is breaking news out of montreal valley of pharma inc vph in canada vphif in america and vp 2 in frankfurt germany a
Canadian pharmaceutical company announced today that health canada has issued a notice of compliance for radeska and radeska hp low molecular weight heparin l-m-w-h biosimilars this is valiopharma the regulatory approval of redeska is a significant corporate milestone for valio and also great news for the canadian healthcare system mandatory use of biosimilars is
Increasingly being adopted across the country and expect it to help provide significant savings that’s right significant savings to provide health care plans said steve saviock president and ceo with more than eight years of proven in market safety internationally and a robust supply chain ensuring product availability we expect radesca to play a major role in the
Achievement of our growth objectives the canadian lmwh market is an access of 200 million annually and our complete product line and differentiating clinic package will be a beneficial factor helping to rapidly secure market share in provinces across canada at did mr saviock in addition to being used primarily for treating and preventing deep vein thrombosis and
Pulmonary embolism lmwh are also now increasingly used as a first line of defense tool in the fight against covid19 yet another covid19 weapon the world health organization who issued guidance regarding the prophylaxis use of lmwh to help prevent complications in the clinical management of severe acute respiratory infections when novel coronavirus cova-19 infection
Is suspected digital investor awareness program the company also announced it has launched a 12-month digital investor awareness program through agora calm interesting agoracom and ourselves do a lot of different deals together a multi-faceted digital platform operated by gorecom internet service corp in order to enhance information availability for current and
Future stakeholders the company has agreed to renumerate agoracom 75 000 plus taxes for the above mentioned services a first service payment of 15 000 was made on december 7 2020 with the remaining balance split equally and due on each of february 27 2021 may 27 2021 august 27 2021 and december 31st 2021 so that’s an entire year of visibility payment will be
Made through the issuance of companies common shares with the number of common shares to be issued determined by the using and the closing price on each above date common shares issued to agoracom under this agreement will be subject to a four month hold period so they are going to get a lot of eyeballs about radesca is a low molecule weight harperin biosimilar
Lmwhs are injectable anti-coagulant drugs used primarily to treat and prevent deep vein thrombosis and pulmonary embolism radesca has more than eight years of proven in-market safety internationally and more than 150 million patient days treated in europe alone about vallejo pharma valiopharma is a pharmaceutical company dedicated to the commercialization of
Innovative prescription products in canada with a focus of neurodegenerative diseases oncology and hospital specialty products headquartered in kirkland quebec vallejo pharma has the full capability and complete infrastructure to register and properly manage its growing product portfolio through all stages of commercialization we can go to value pharma website
It looks like this and we did bring you this pick when it was under 80 cents and today like i said it trades at a dollar 31 up three percent on this news so far and i believe that the story is just getting started now let’s go to otc markets and we’re just going to quickly look at their share structure fully reporting bulletin board company in america highest
Tiered exchange and if we go to securities detailed other than the otcqx which is actually the highest tiered exchange that’s not a senior exchange but this is what i love about them tight share structure only 15 million shares in the float love the float 64 million outstanding shares and a baby market cap of only 60 million market cap i believe we see this go
Over well over 100 million market cap and they’ve already been a success for our community congratulations everyone who got in for the win on valeo pharma and i believe that this is a story that’s just getting started love to know your opinion if you like this video please smash the like button comment down below share the video everywhere this is rich from rich
To be live bringing you the news on valio pharma announcing the big news for radeska paliopharma announces health canada approval for radesca trademark and radeska hp trademark really big news for valeo pharma and this is a story that is just getting better seems like every single day the story just gets better love to know what you guys think if you like this
Video please smash the like button comment down below share the video everywhere this is rich for merch to be live if you’re not winning you’re not watching we bring in the winners and we bring them to you first valiopharma big winner for our community and i believe that this story is just getting started love to know what you think comment down below if you
Haven’t subscribed subscribe and share this video everywhere so that the world that is watching can win big thank you guys we’ll talk to you soon peace another big winner you can book it amo we’ll see you soon
Transcribed from video
VALEO PHARMA ANNOUNCES HEALTH CANADA APPROVAL FOR REDESCA(TM) AND REDESCA HP(TM) (VPH) (VPHIF) (VP2) By RICH TV LIVE
